» Articles » PMID: 8174838

Glycated Haemoglobin Predicts Progression to Diabetes Mellitus in Pima Indians with Impaired Glucose Tolerance

Overview
Journal Diabetologia
Specialty Endocrinology
Date 1994 Mar 1
PMID 8174838
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Glycated haemoglobin could offer several practical advantages over the OGTT for assessing glucose metabolism. Initial cross-sectional studies (1983-1985) on 381 subjects (mostly Pima Indians) described the relationship between HbA1c (a specific glycated Hb) and the OGTT. We performed follow-up OGTTs and HbA1c measurements on 257 of these same subjects 1.6-6.1 years later. Subjects were again grouped according to both the result of the OGTT (normal, IGT or diabetes, by WHO criteria) and HbA1c result (normal or elevated based on mean +/- 1.96 SD of normal). Of 66 subjects with IGT at baseline, 47 (71%) had normal HbA1c and 19 (29%) had elevated HbA1c. Twenty-six (39%) of these subjects had diabetes at follow-up. Of these subjects with IGT, a significantly greater percentage of subjects with elevated HbA1c at baseline (68%) showed worsening to diabetes than those with a normal HbA1c (28%); (chi-square = 7.8, df = 1, p < 0.01). Thus, in subjects with IGT, glycated Hb may be a useful predictor of progression to diabetes.

Citing Articles

Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus.

Sacks D, Arnold M, Bakris G, Bruns D, Horvath A, Lernmark A Diabetes Care. 2023; 46(10):e151-e199.

PMID: 37471273 PMC: 10516260. DOI: 10.2337/dci23-0036.


Estimation of the contribution of biomarkers of different metabolic pathways to risk of type 2 diabetes.

Montonen J, Drogan D, Joost H, Boeing H, Fritsche A, Schleicher E Eur J Epidemiol. 2010; 26(1):29-38.

PMID: 21188480 DOI: 10.1007/s10654-010-9539-0.


Incidence of type 2 diabetes using proposed HbA1c diagnostic criteria in the european prospective investigation of cancer-norfolk cohort: implications for preventive strategies.

Chamnan P, Simmons R, Forouhi N, Luben R, Khaw K, Wareham N Diabetes Care. 2010; 34(4):950-6.

PMID: 20622160 PMC: 3064056. DOI: 10.2337/dc09-2326.


A1C level and future risk of diabetes: a systematic review.

Zhang X, Gregg E, Williamson D, Barker L, Thomas W, Bullard K Diabetes Care. 2010; 33(7):1665-73.

PMID: 20587727 PMC: 2890379. DOI: 10.2337/dc09-1939.


International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes.

Diabetes Care. 2009; 32(7):1327-34.

PMID: 19502545 PMC: 2699715. DOI: 10.2337/dc09-9033.


References
1.
. Feasibility of centralized measurements of glycated hemoglobin in the Diabetes Control and Complications Trial: a multicenter study. The DCCT Research Group. Clin Chem. 1987; 33(12):2267-71. View

2.
FLOCK E, BENNETT P, Savage P, Webner C, Howard B, RUSHFORTH N . Bimodality of glycosylated hemoglobin distribution in Pima Indians: relationship to fasting hyperglycemia. Diabetes. 1979; 28(11):984-9. DOI: 10.2337/diab.28.11.984. View

3.
Ferrell R, Hanis C, Aguilar L, Tulloch B, Garcia C, Schull W . Glycosylated hemoglobin determination from capillary blood samples. Utility in an epidemiologic survey of diabetes. Am J Epidemiol. 1984; 119(2):159-66. DOI: 10.1093/oxfordjournals.aje.a113734. View

4.
. Diabetes mellitus. Report of a WHO Study Group. World Health Organ Tech Rep Ser. 1985; 727:1-113. View

5.
Hall P, Cook J, Sheldon J, Rutherford S, GOULD B . Glycosylated hemoglobins and glycosylated plasma proteins in the diagnosis of diabetes mellitus and impaired glucose tolerance. Diabetes Care. 1984; 7(2):147-50. DOI: 10.2337/diacare.7.2.147. View